OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New insights into cytotoxic mechanisms of bozepinib against glioblastoma
Amanda de Fraga Dias, Juliete Nathali Scholl, César Eduardo Jacintho Moritz, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 162, pp. 105823-105823
Open Access | Times Cited: 6
Amanda de Fraga Dias, Juliete Nathali Scholl, César Eduardo Jacintho Moritz, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 162, pp. 105823-105823
Open Access | Times Cited: 6
Showing 6 citing articles:
Nanosystems at Nexus: Navigating Nose-to-Brain Delivery for Glioblastoma Treatment
Tejas Girish Agnihotri, Akanksha Dahifale, Shyam Sudhakar Gomte, et al.
Molecular Pharmaceutics (2025)
Closed Access
Tejas Girish Agnihotri, Akanksha Dahifale, Shyam Sudhakar Gomte, et al.
Molecular Pharmaceutics (2025)
Closed Access
CD73 in glioblastoma: Where are we now and what are the future directions?
Nicolly Espindola Gelsleichter, Juliana H. Azambuja, Dominique S. Rubenich, et al.
Immunology Letters (2023) Vol. 256-257, pp. 20-27
Closed Access | Times Cited: 7
Nicolly Espindola Gelsleichter, Juliana H. Azambuja, Dominique S. Rubenich, et al.
Immunology Letters (2023) Vol. 256-257, pp. 20-27
Closed Access | Times Cited: 7
Targeting ecto-5′-nucleotidase: A comprehensive review into small molecule inhibitors and expression modulators
Gustavo Machado das Neves, Luciano Porto Kagami, Ana Maria Oliveira Battastini, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115052-115052
Closed Access | Times Cited: 9
Gustavo Machado das Neves, Luciano Porto Kagami, Ana Maria Oliveira Battastini, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115052-115052
Closed Access | Times Cited: 9
Design, synthesis, HER2 inhibition and anticancer evaluation of new substituted 1,5-dihydro-4,1-benzoxazepines
Olga Cruz‐López, Matilde Ner, Francho Nerín-Fonz, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1551-1561
Open Access | Times Cited: 10
Olga Cruz‐López, Matilde Ner, Francho Nerín-Fonz, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1551-1561
Open Access | Times Cited: 10
Development of Bozepinib-Loaded Nanocapsules for Nose-To-Brain Delivery: Preclinical Evaluation in Glioblastoma
Amanda de Fraga Dias, Danieli Rosane Dallemole, Franciele Aline Bruinsmann, et al.
Nanomedicine (2021) Vol. 16, Iss. 23, pp. 2095-2115
Open Access | Times Cited: 8
Amanda de Fraga Dias, Danieli Rosane Dallemole, Franciele Aline Bruinsmann, et al.
Nanomedicine (2021) Vol. 16, Iss. 23, pp. 2095-2115
Open Access | Times Cited: 8
Preclinical evaluation of bozepinib in bladder cancer cell lines: modulation of the NPP1 enzyme
Álisson Coldebella da Silva, Juliete Nathali Scholl, Amanda de Fraga Dias, et al.
Purinergic Signalling (2023)
Closed Access | Times Cited: 1
Álisson Coldebella da Silva, Juliete Nathali Scholl, Amanda de Fraga Dias, et al.
Purinergic Signalling (2023)
Closed Access | Times Cited: 1
